New Drug Applications Pain Therapeutics Announces Feedback from Recent Meeting With FDA on Remoxy 6 years ago
New Drug Applications FDA Grants Priority Review for Daiichi Sankyo’s New Drug Application for CSF1R Inhibitor Pexidartinib for Treatment of Patients with TGCT, a Rare, Debilitating Tumor 6 years ago
New Drug Applications Zogenix Submits New Drug Application to U.S. Food & Drug Administration for Fintepla for the Treatment of Dravet Syndrome 6 years ago
New Drug Applications FDA Advisory Committee Recommends Approval of Spravato (esketamine) Nasal Spray for Adults with Treatment-Resistant Depression 6 years ago